[go: up one dir, main page]

GB9914861D0 - Tetanus toxin polypeptides - Google Patents

Tetanus toxin polypeptides

Info

Publication number
GB9914861D0
GB9914861D0 GBGB9914861.1A GB9914861A GB9914861D0 GB 9914861 D0 GB9914861 D0 GB 9914861D0 GB 9914861 A GB9914861 A GB 9914861A GB 9914861 D0 GB9914861 D0 GB 9914861D0
Authority
GB
United Kingdom
Prior art keywords
tetanus toxin
toxin polypeptides
polypeptides
tetanus
toxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9914861.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial College of London
Original Assignee
Imperial College of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College of London filed Critical Imperial College of London
Priority to GBGB9914861.1A priority Critical patent/GB9914861D0/en
Publication of GB9914861D0 publication Critical patent/GB9914861D0/en
Priority to AU55512/00A priority patent/AU5551200A/en
Priority to PCT/GB2000/002428 priority patent/WO2001000839A1/en
Priority to EP00940598A priority patent/EP1196584A1/en
Priority to JP2001506831A priority patent/JP2003503059A/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB9914861.1A 1999-06-25 1999-06-25 Tetanus toxin polypeptides Ceased GB9914861D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9914861.1A GB9914861D0 (en) 1999-06-25 1999-06-25 Tetanus toxin polypeptides
AU55512/00A AU5551200A (en) 1999-06-25 2000-06-23 Tetanus toxin polypeptides
PCT/GB2000/002428 WO2001000839A1 (en) 1999-06-25 2000-06-23 Tetanus toxin polypeptides
EP00940598A EP1196584A1 (en) 1999-06-25 2000-06-23 Tetanus toxin polypeptides
JP2001506831A JP2003503059A (en) 1999-06-25 2000-06-23 Tetanus toxin polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9914861.1A GB9914861D0 (en) 1999-06-25 1999-06-25 Tetanus toxin polypeptides

Publications (1)

Publication Number Publication Date
GB9914861D0 true GB9914861D0 (en) 1999-08-25

Family

ID=10856045

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9914861.1A Ceased GB9914861D0 (en) 1999-06-25 1999-06-25 Tetanus toxin polypeptides

Country Status (5)

Country Link
EP (1) EP1196584A1 (en)
JP (1) JP2003503059A (en)
AU (1) AU5551200A (en)
GB (1) GB9914861D0 (en)
WO (1) WO2001000839A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192596B2 (en) 1996-08-23 2007-03-20 The Health Protection Agency Ipsen Limited Recombinant toxin fragments
US8012491B2 (en) 1996-08-23 2011-09-06 Syntaxin, Ltd. Recombinant toxin fragments
GB9617671D0 (en) 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
CN119954917A (en) * 2017-12-15 2025-05-09 威斯康星州医药大学股份有限公司 Modified Clostridial neurotoxins and conjugate vaccine platforms as vaccines
CN117964751A (en) * 2018-03-13 2024-05-03 斯米维特公司 Single domain antibody that binds to tetanus neurotoxin
EP4134133A1 (en) * 2018-07-31 2023-02-15 Snoretox Pty Ltd Pegylated tetanus neurotoxins and treatment of hypotonia
US12344635B2 (en) 2020-03-24 2025-07-01 The Medical College Of Wisconsin, Inc. COVID-19 vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516442D0 (en) * 1985-06-28 1985-07-31 Wellcome Found Cloned antigen
AU4545393A (en) * 1992-06-30 1994-01-24 United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Peptide which produces protective immunity against tetanus

Also Published As

Publication number Publication date
AU5551200A (en) 2001-01-31
JP2003503059A (en) 2003-01-28
EP1196584A1 (en) 2002-04-17
WO2001000839A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
AU8441801A (en) Novel polypeptide
GB9923177D0 (en) Novel polypeptide
GB9914861D0 (en) Tetanus toxin polypeptides
GB0015761D0 (en) Polypeptide
GB9923889D0 (en) Novel polypeptide
GB9924951D0 (en) Novel polypeptide
EP1179540A4 (en) Novel polypeptide
GB9916245D0 (en) Tetanus toxin polypeptides
GB9920000D0 (en) Polypeptides
GB9923893D0 (en) Novel polypeptide
GB9923890D0 (en) Novel polypeptide
GB9918680D0 (en) Polypeptide
EP1354947A4 (en) Novel polypeptide
GB9924960D0 (en) Novel polypeptide
GB9925115D0 (en) Novel polypeptide
GB9923888D0 (en) Novel polypeptide
GB0018307D0 (en) Polypeptides
GB9924956D0 (en) Novel polypeptide
GB0113257D0 (en) Polypeptides
GB9906307D0 (en) Novel polypeptides
GB0018238D0 (en) Novel polypeptide
GB0124030D0 (en) Novel polypeptide
GB0009070D0 (en) Novel polypeptide
GB0031304D0 (en) Novel polypeptide
GB0009973D0 (en) Novel polypeptide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)